Crescent Biopharma, Inc. (CBIO) support and resistance · rev $1.0M
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
This page maps Crescent Biopharma, Inc. (CBIO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CBIO revenue for 2026-06-30 was $1.0M. Net income was -$48.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. CBIO currently screens at market cap $491.3M.
CBIO currently screens at market cap $491.3M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CBIO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CBIO quote page for the session range and the stock page for the full model.
Not investment advice.